Suppr超能文献

淋巴管播散性癌病作为原发性肺印戒细胞腺癌的首发表现:一例报告

Lymphangitic carcinomatosis as the initial manifestation of primary signet-ring cell adenocarcinoma of the lung: A case report.

作者信息

Corredor-Orlandelli David, Vargas Lina

机构信息

School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.

Internal Medicine Department, Fundación Cardioinfantil - LaCardio, Bogotá, Colombia.

出版信息

Rare Tumors. 2023 Mar 13;15:20363613231164017. doi: 10.1177/20363613231164017. eCollection 2023.

Abstract

Signet-ring cell carcinomas are an aggressive, poorly differentiated, and highly invasive adenocarcinoma carrying a poor prognosis. Most of these tumors originate in gastrointestinal organs; however, primary lung signet-ring cell adenocarcinomas can rarely occur. Tumoral lymphatic infiltration is a complication of these tumors and can cause phenomena such as lymphangitic carcinomatosis, characterized by a nodular thickening of the pleura, pleural effusions, and mediastinal lymphadenopathies. We report a case of a 63-year-old ex-smoker with a 2-week clinical course of dyspnea and pleuritic chest pain in which a nodular thickening of the pleura and pleural effusion were documented and led to the diagnosis of a primary signet-ring cell adenocarcinoma of the lung with lymphangitic carcinomatosis. This complication has never been described in the context of a primary lung tumor of this subtype. Both entities carry a high mortality and have no therapeutical options. This report adds to the information available about them.

摘要

印戒细胞癌是一种侵袭性强、低分化且高度浸润的腺癌,预后较差。这些肿瘤大多起源于胃肠道器官;然而,原发性肺印戒细胞腺癌很少见。肿瘤性淋巴浸润是这些肿瘤的一种并发症,可导致诸如淋巴管癌病等现象,其特征为胸膜结节状增厚、胸腔积液和纵隔淋巴结肿大。我们报告一例63岁有吸烟史的患者,临床病程为2周的呼吸困难和胸膜炎性胸痛,其中记录到胸膜结节状增厚和胸腔积液,最终诊断为原发性肺印戒细胞腺癌伴淋巴管癌病。这种并发症在这种亚型的原发性肺肿瘤中从未有过描述。这两种情况都具有高死亡率且没有治疗选择。本报告增加了关于它们的现有信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce1d/10014970/8db60e35c3e6/10.1177_20363613231164017-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验